The whole underlying theme here is this stigma and bias of not recognizing obesity as a disease like we do cancer and diabetes and everything else, says Florencia Halperin, an endocrinologist and chief medical officer at Form Health, an online medical weight loss clinic, For cancer, you would never have an employer who says, We're not covering this. Amanda Bonello, founder and CEO of the GLP-1 Collective, a nonprofit organization aiming to help patients access these medications, is not surprised at the lengths patients are going to
Food and Drug Administration (FDA) have not approved retatrutide yet
Labeling and Instructions: Medication instructions will usually specify which type of diluent to use
90% of total demand is lost due to payer friction, abandonment, and non-persistence
Second, how you raise NAD matters more than just taking a supplement